The NALP3 inflammasome is involved in neurotoxic prion peptide-induced microglial activation

Journal of Neuroinflammation

Volumn 9, Issue , 2012, Pages

  Shi, Fushan ^a   Yang, Lifeng ^a   Kouadir, Mohammed ^a   Yang, Yang ^a   Wang, Jihong ^a   Zhou, Xiangmei ^a   Yin, Xiaomin ^a   Zhao, Deming ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

IL 1 ; Microglia; NALP3 inflammasome; Prion diseases; PrP106 126

Indexed keywords

APOPTOSIS ASSOCIATED SPECK LIKE PROTEIN; CRYOPYRIN; CYTOPLASM PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MESSENGER RNA; NEUROTOXIN; POTASSIUM; PRION PROTEIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE SILENCING; INFLAMMATION; MICROGLIA; MOUSE; NERVE CELL STIMULATION; NEWBORN; NONHUMAN; POLYMERASE CHAIN REACTION; POTASSIUM TRANSPORT; PROTEIN DEPLETION; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; TRANSCRIPTION INITIATION; UPREGULATION; WESTERN BLOTTING;

EID: 84859933609     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-73     Document Type: Article

References (42)

1. Scott J. Scrapie pathogenesis. Br Med Bull 1993, 49:778.
2. Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I, Huang Z, Fletterick RJ, Cohen FE. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA 1993, 90:10962-10966. 10.1073/pnas.90.23.10962, 47901, 7902575.
3. Prusiner SB. Molecular biology of prion diseases. Science 1991, 252:1515. 10.1126/science.1675487, 1675487.
4. Henriques ST, Pattenden LK, Aguilar MI, Castanho MARB. PrP (106-126) does not interact with membranes under physiological conditions. Biophys J 2008, 95:1877-1889. 10.1529/biophysj.108.131458, 2483773, 18469080.
5. Forloni G, Angeretti N, Chiesa R, Monzani E, Salmona M, Bugiani O, Tagliavini F. Neurotoxicity of a prion protein fragment. Nature 1993, 362:543-546. 10.1038/362543a0, 8464494.
6. Selvaggini C, Degioia L, Cantu L, Ghibaudi E, Diomede L, Passerini F, Forloni G, Bugiani O, Tagliavini F, Salmona M. Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. Biochem Biophys Res Commun 1993, 194:1380-1386. 10.1006/bbrc.1993.1977, 8102526.
7. Giese A, Brown DR, Groschup MH, Feldmann C, Haist I, Kretzschmar HA. Role of microglia in neuronal cell death in prion disease. Brain Pathol 1998, 8:449-457.
8. Marella M, Chabry J. Neurons and astrocytes respond to prion infection by inducing microglia recruitment. J Neurosci 2004, 24:620. 10.1523/JNEUROSCI.4303-03.2004, 14736847.
9. Rock RB, Gekker G, Hu S, Sheng WS, Cheeran M, Lokensgard JR, Peterson PK. Role of microglia in central nervous system infections. Clin Microbiol Rev 2004, 17:942-964. 10.1128/CMR.17.4.942-964.2004, 523558, 15489356.
10. Tribouillard-Tanvier D, Striebel JF, Peterson KE, Chesebro B. Analysis of protein levels of 24 cytokines in scrapie agent-infected brain and glial cell cultures from mice differing in prion protein expression levels. J Virol 2009, 83:11244. 10.1128/JVI.01413-09, 2772806, 19710140.
11. Dinarello CA. A signal for the caspase-1 inflammasome free of TLR. Immunity 2007, 26:383-385. 10.1016/j.immuni.2007.04.005, 17459804.
12. Peyrin JM, Lasmézas CI, Haïk S, Tagliavini F, Salmona M, Williams A, Richie D, Deslys JP, Dormont D. Microglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines. Neuroreport 1999, 10:723. 10.1097/00001756-199903170-00012, 10208538.
13. Yang L, Zhou X, Yang J, Yin X, Han L, Zhao D. Aspirin inhibits cytotoxicity of prion peptide PrP106-126 to neuronal cells associated with microglia activation in vitro. J Neuroimmunol 2008, 199:10-17. 10.1016/j.jneuroim.2008.04.028, 18547651.
14. Garção P, Oliveira CR, Agostinho P. Comparative study of microglia activation induced by amyloid-beta and prion peptides: role in neurodegeneration. J Neurosci Res 2006, 84:182-193. 10.1002/jnr.20870, 16634056.
15. Crozet C, Beranger F, Lehmann S. Cellular pathogenesis in prion diseases. Vet Res 2008, 39:44. 10.1051/vetres:2008021, 18413130.
16. Lamkanfi M, Dixit VM. The inflammasomes. PLoS Pathog 2009, 5:e1000510. 10.1371/journal.ppat.1000510, 2791419, 20041168.
17. Mariathasan S, Monack DM. Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat Rev Immunol 2007, 7:31-40. 10.1038/nri1997, 17186029.
18. Tschopp J, Martinon F, Burns K. NALPs: a novel protein family involved in inflammation. Nat Rev Mol Cell Bio 2003, 4:95-104.
19. Martinon F, Pétrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006, 440:237-241. 10.1038/nature04516, 16407889.
20. Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M, Lee WP, Weinrauch Y, Monack DM, Dixit VM. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006, 440:228-232. 10.1038/nature04515, 16407890.
21. Henn A, Lund S, Hedtjärn M, Schrattenholz A, Pörzgen P, Leist M. The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. ALTEX 2009, 26:83-94.
22. Wong ML, Medrano JF. Real-time PCR for mRNA quantitation. Biotechniques 2005, 39:75-85. 10.2144/05391RV01, 16060372.
23. Dostert C, Pétrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008, 320:674. 10.1126/science.1156995, 2396588, 18403674.
24. Srinivasula SM, Poyet JL, Razmara M, Datta P, Zhang ZJ, Alnemri ES. The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J Biol Chem 2002, 277:21119-21122. 10.1074/jbc.C200179200, 11967258.
25. Sutterwala FS, Ogura Y, Szczepanik M, Lara-Tejero M, Lichtenberger GS, Grant EP, Bertin J, Coyle AJ, Galán JE, Askenase PW. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 2006, 24:317-327. 10.1016/j.immuni.2006.02.004, 16546100.
26. Petrilli V, Papin S, Dostert C, Mayor A, Martinon F, Tschopp J. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ 2007, 14:1583-1589. 10.1038/sj.cdd.4402195, 17599094.
27. Tschopp J, Schroder K. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?. Nat Rev Immunol 2010, 10:210-215. 10.1038/nri2725, 20168318.
28. Bacot SM, Lenz P, Frazier-Jessen MR, Feldman GM. Activation by prion peptide PrP106-126 induces a NF-κB-driven proinflammatory response in human monocyte-derived dendritic cells. J Leukoc Biol 2003, 74:118-125. 10.1189/jlb.1102521, 12832450.
29. Julius C, Heikenwalder M, Schwarz P, Marcel A, Karin M, Prinz M, Pasparakis M, Aguzzi A. Prion propagation in mice lacking central nervous system NF-κB signalling. J Gen Virol 2008, 89:1545-1550. 10.1099/vir.0.83622-0, 18474572.
30. Davis BK, Wen H, Ting JPY. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol 2011, 29:707-735. 10.1146/annurev-immunol-031210-101405, 21219188.
31. Franchi L, Eigenbrod T, Muñoz-Planillo R, Nuñez G. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 2009, 10:241-247. 2820724, 19221555.
32. Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol 2009, 27:229-265. 10.1146/annurev.immunol.021908.132715, 19302040.
33. Latz E. The inflammasomes: mechanisms of activation and function. Curr Opin Immunol 2010, 22:28-33. 10.1016/j.coi.2009.12.004, 2844336, 20060699.
34. Hanamsagar R, Torres V, Kielian T. Inflammasome activation and IL-1β/IL-18 processing are influenced by distinct pathways in microglia. J Neurochem 2011, 119:736-748. 10.1111/j.1471-4159.2011.07481.x, 21913925.
35. Kouadir M, Yang L, Tan R, Shi F, Lu Y, Zhang S, Yin X, Zhou X, Zhao D. CD36 participates in PrP106-126-induced activation of microglia. PLoS One 2012, 7:e30756. 10.1371/journal.pone.0030756, 3266924, 22292032.
36. Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, Fitzgerald KA, Latz E, Moore KJ, Golenbock DT. The NALP3 inflammasome is involved in the innate immune response to amyloid-β. Nat Immunol 2008, 9:857-865. 10.1038/ni.1636, 3101478, 18604209.
37. Masters SL, Dunne A, Subramanian SL, Hull RL, Tannahill GM, Sharp FA, Becker C, Franchi L, Yoshihara E, Chen Z. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1 [beta] in type 2 diabetes. Nat Immunol 2010, 11:897-904. 10.1038/ni.1935, 3103663, 20835230.
38. Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999, 18:6853. 10.1038/sj.onc.1203239, 10602461.
39. Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 2009, 11:136-140.
40. Meissner F, Molawi K, Zychlinsky A. Superoxide dismutase 1 regulates caspase-1 and endotoxic shock. Nat Immunol 2008, 9:866-872. 10.1038/ni.1633, 18604212.
41. Hsu LC, Ali SR, McGillivray S, Tseng PH, Mariathasan S, Humke EW, Eckmann L, Powell JJ, Nizet V, Dixit VM, Karin M. A NOD2-NALP1 complex mediates caspase-1-dependent IL-1β secretion in response to Bacillus anthracis infection and muramyl dipeptide. Proc Natl Acad Sci USA 2008, 180:7803-7808.
42. Warren SE, Mao DP, Rodriguez AE, Miao EA, Aderem A. Multiple Nod-like receptors activate caspase 1 during Listeria monocytogenes infection. J Immunol 2008, 180:7558-7564. 2991040, 18490757.